IL Pharmaceuticals

Scisparc Ltd (SPRC)

Track

Over the past 90 days, Scisparc Ltd recorded three insider transactions totaling a net value of approximately $4,620 in sales. A 10% stockholder filed proposed sales of shares, while another insider executed a direct sale. These activities occurred amid a 34.5% decline in the stock price over the same period.
Ticker: SPRC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 22 Jun 2026
Value US$2,885,851.04 | Price 95.37 | Shares 46,233
Proposed sale 22 Jun 2026
Value US$4,568,845.55 | Price 388.49 | Shares 83,203
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-22 PrS Proposed sale
SMITH JAMES EDMOND

10% Stockholder

Large shareholder
46,233
95.37
US$2,885,851 		46,233 95.37 US$2,885,851
2026-06-22 2026-06-22 PrS Proposed sale
SMITH JAMES EDMOND

10% Stockholder

Large shareholder
83,203
388.49
US$4,568,846 		83,203 388.49 US$4,568,846
2026-06-03 2026-06-01 S Sale
Shrem Itschak
Non-Executive Director
61,009 -28.6%
188.20
US$4,562,731 		61,009 -28.6% 188.20 US$4,562,731
2023-08-21 2023-08-17 PrS Proposed sale
MOSHE REVACH

DIRECTOR

Non-Executive Director
108,185
0.18
US$19,473 		108,185 0.18 US$19,473
Explore more

More insider trading research around Scisparc Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity